Real‐world effectiveness and safety of tildrakizumab in long‐term treatment of plaque psoriasis: Results from the non‐interventional, prospective, multicentre study TILOT

por Tsianakas, Athanasios, Schwichtenberg, Uwe, Pierchalla, Peter, Hinz, Torsten, Diemert, Sebastian, Korge, Bernhard
Publicado 2022

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

por Reich, Kristian, Korge, Bernhard, Magnolo, Nina, Manasterski, Maria, Schwichtenberg, Uwe, Staubach-Renz, Petra, Kaiser, Stephan, Roemmler-Zehrer, Josefine, Gómez, Natalie Núnez, Lorenz-Baath, Katrin
Publicado 2021